Royal Bank of Canada »

Atea Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 30k 3.07
2023-09-30 $37k 14k 2.60
2023-06-30 $30k 8.0k 3.75
2022-12-31 $52k 11k 4.83
2022-09-30 $27k 4.5k 6.00
2021-06-30 $143k 6.2k 23.26
2021-03-31 $60k 977 61.40
2020-12-31 $15k 362 41.44